PETMED EXPRESS INC (PETS)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $200k
- Apr 30 · No plan
- Form 4 sales
- 174
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Apr 30, 2025No plan
Campos Sandra Yvette, CEO & President, sold 9.5% of their holdings
$200k60,463 shares at $3.31
- Aug 15, 2024No plan
Smith Jacqueline Paula, Other, sold 2.9% of their holdings
$2k601 shares at $3.19
- Jun 2, 2021Plan not stated
Rosenbloom Bruce S, CFO & Treasurer, sold 16.4% of their holdings
$255k6,000 shares at $42.50
- Jan 29, 2021Plan not stated
Formica Frank J, Director, sold 8.3% of their holdings
$193k5,000 shares at $38.59
- Jan 28, 2021Plan not stated
Fulgoni Gian, Director, sold 19.4% of their holdings
$607k12,890 shares at $47.13
- Jan 28, 2021Plan not stated
Rosenbloom Bruce S, CFO & Treasurer, sold 12% of their holdings
$250k5,000 shares at $50.00
- Jan 27, 2021Plan not stated
Akdag Menderes, CEO & President, sold 15.1% of their holdings
$2.7M60,000 shares at $45.50
- Jan 13, 2021Plan not stated
Korn Ronald J, Director, sold 2.3% of their holdings
$70k2,000 shares at $35.00
- Dec 24, 2020Plan not stated
Korn Ronald J, Director, sold 2.3% of their holdings
$68k2,000 shares at $34.00
- Dec 18, 2020Plan not stated
Korn Ronald J, Director, sold 2.2% of their holdings
$66k2,000 shares at $33.00
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Nov 6, 2026 | PETS | Krulik Douglas | CAO and Interim CFO | Withheld for tax | 11,892 | $2.03 | $24k | 90,608 | SEC |
| Sep 28, 2026 | Sep 29, 2026 | PETS | Willard Jeffrey Allen | CEO and President | AwardedPerformance Share Units | 250,000 | 250,000 | SEC | ||
| Sep 28, 2026 | Sep 29, 2026 | PETS | Willard Jeffrey Allen | CEO and President | Awarded | 250,000 | 250,000 | SEC | ||
| Sep 17, 2026 | Sep 21, 2026 | PETS | Elkeles Tamar | Director | Awarded | 49,923 | 49,923 | SEC | ||
| Aug 11, 2026 | Aug 12, 2026 | PETS | Batushansky Peter | Director | Awarded | 55,555 | 91,928 | SEC | ||
| Aug 11, 2026 | Aug 12, 2026 | PETS | Mennen Justin L. | Director | Awarded | 55,555 | 98,274 | SEC | ||
| Aug 11, 2026 | Aug 13, 2026 | PETS | Campbell Leslie C.G. | Interim CEO and President | Awarded | 60,000 | 145,000 | SEC | ||
| Aug 11, 2026 | Aug 12, 2026 | PETS | LaCamp James | Director | Awarded | 55,555 | 90,421 | SEC | ||
| Jun 26, 2026 | Jun 26, 2026 | PETS | Krulik Douglas | CAO and Interim CFO | AwardedPerformance Share Units | 32,500 | 32,500 | SEC | ||
| Jun 26, 2026 | Jun 26, 2026 | PETS | Krulik Douglas | CAO and Interim CFO | Awarded | 32,500 | 102,500 | SEC | ||
| Jun 8, 2026 | Jun 9, 2026 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 25,000 | $1.75 | $44k | 2.6M | SEC |
| Jan 21, 2026 | Jan 23, 2026 | PETS | Fulgoni Gian | Director | Returned to the company | 26,057 | 132,299 | SEC | ||
| Oct 30, 2025 | Nov 3, 2025 | PETS | Batushansky Peter | Director | Awarded | 33,846 | 36,373 | SEC | ||
| Oct 30, 2025 | Nov 3, 2025 | PETS | Krulik Douglas | CAO and Interim CFO | Awarded | 20,000 | 70,000 | SEC | ||
| Oct 30, 2025 | Nov 3, 2025 | PETS | Solivan Leah | Director | Awarded | 33,846 | 42,289 | SEC | ||
| Oct 30, 2025 | Nov 3, 2025 | PETS | Mennen Justin L. | Director | Awarded | 33,846 | 42,719 | SEC | ||
| Oct 30, 2025 | Nov 14, 2025 | PETS | Fulgoni Gian | Director | Awarded | 33,846 | 158,356 | SEC | ||
| Oct 30, 2025 | Nov 3, 2025 | PETS | LaCamp James | Director | Awarded | 34,866 | 34,866 | SEC | ||
| Sep 9, 2025 | Sep 11, 2025 | PETS | Krulik Douglas | Chief Accounting Officer | Awarded | 10,000 | 50,000 | SEC | ||
| Aug 13, 2025 | Aug 14, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 101,000 | $3.17 | $320k | 2.6M | SEC |
| Aug 1, 2025 | Aug 4, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 118,200 | $3.21 | $379k | 2.5M | SEC |
| Jul 21, 2025 | Jul 22, 2025 | PETS | Tache Galante Moises | 10% owner | Bought | 25,000 | $3.50 | $88k | 2.6M | SEC |
| Jul 18, 2025 | Jul 21, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 17,565 | $3.23 | $57k | 2.4M | SEC |
| Jul 17, 2025 | Jul 18, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 31,701 | $3.15 | $100k | 2.3M | SEC |
| Jul 2, 2025 | Jul 3, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 2,817 | $3.22 | $9k | 2.3M | SEC |
| Jul 1, 2025 | Jul 2, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 694 | $3.21 | $2k | 2.3M | SEC |
| Jun 3, 2025 | Jun 4, 2025 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 25,000 | $3.94 | $99k | 2.5M | SEC |
| May 21, 2025 | May 23, 2025 | PETS | Nina Capital Holdings INC. | 10% owner | Bought | 25,000 | $3.86 | $97k | 2.5M | SEC |
| May 20, 2025 | May 22, 2025 | PETS | Silvercape Investments Ltd | 10% owner | Bought | 7,401 | $3.95 | $29k | 2.3M | SEC |
| Apr 30, 2025 | May 2, 2025 | PETS | Campos Sandra Yvette | CEO & President | Sold | 60,463 | $3.31 | $200k | 578,524 | SEC |
| Apr 9, 2025 | Apr 11, 2025 | PETS | Batushansky Peter | Director | Awarded | 2,527 | 2,527 | SEC | ||
| Mar 18, 2025 | Mar 19, 2025 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 100,000 | $4.09 | $409k | 2.5M | SEC |
| Mar 10, 2025 | Mar 11, 2025 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 100,000 | $4.11 | $411k | 2.4M | SEC |
| Mar 3, 2025 | Mar 4, 2025 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 50,000 | $4.33 | $217k | 2.3M | SEC |
| Feb 3, 2025 | Feb 4, 2025 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 25,000 | $4.82 | $121k | 2.3M | SEC |
| Jan 27, 2025 | Jan 28, 2025 | PETS | Tache Galante Moises | 10% owner | Bought | 50,000 | $4.80 | $240k | 2.2M | SEC |
| Jan 15, 2025 | Jan 17, 2025 | PETS | Campos Sandra Yvette | CEO & President | AwardedPerformance Share Units | 146,772 | 146,772 | SEC | ||
| Jan 15, 2025 | Jan 17, 2025 | PETS | Campos Sandra Yvette | CEO & President | Awarded | 146,772 | 638,987 | SEC | ||
| Jan 15, 2025 | Jan 17, 2025 | PETS | Smith Jacqueline Paula | Other | Awarded | 8,000 | 28,099 | SEC | ||
| Jan 7, 2025 | Jan 10, 2025 | PETS | Matz Zyman Stephannie | 10% owner | Bought | 25,000 | $4.98 | $125k | 2.2M | SEC |
| Dec 16, 2024 | Dec 18, 2024 | PETS | Tache Galante Moises | 10% owner | Bought | 32,000 | $5.66 | $181k | 2.1M | SEC |
| Dec 6, 2024 | Dec 10, 2024 | PETS | Tache Galante Moises | 10% owner | Bought | 40,000 | $5.55 | $222k | 2.1M | SEC |
| Dec 5, 2024 | Dec 6, 2024 | PETS | Campbell Leslie C.G. | Director | Bought | 60,000 | $5.41 | $325k | 30,000 | SEC |
| Sep 27, 2024 | Sep 11, 2025 | PETS | Krulik Douglas | Chief Accounting Officer | Awarded | 40,000 | 40,000 | SEC | ||
| Sep 27, 2024 | Sep 27, 2024 | PETS | D'Elia Robyn M. | Chief Financial Officer | Awarded | 250,000 | 250,000 | SEC | ||
| Sep 9, 2024 | Oct 18, 2024 | PETS | Nina Capital Holdings INC. | 10% owner | Bought | 12,500 | $3.34 | $42k | 2.1M | SEC |
| Aug 15, 2024 | Aug 19, 2024 | PETS | Smith Jacqueline Paula | Other | Sold | 601 | $3.19 | $2k | 20,099 | SEC |
| Aug 8, 2024 | Aug 9, 2024 | PETS | Fulgoni Gian | Director | Awarded | 7,500 | 124,510 | SEC | ||
| Aug 8, 2024 | Aug 9, 2024 | PETS | Solivan Leah | Director | Awarded | 7,500 | 8,443 | SEC | ||
| Aug 8, 2024 | Aug 9, 2024 | PETS | Mennen Justin L. | Director | Awarded | 7,500 | 8,873 | SEC |
Sales, notices and lockups (174)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | May 2, 2025 | Campos Sandra Yvette | PETS | CEO & President | Form 4 sale | 60,463 | $200k | 9.5% | No plan | SEC |
| Aug 15, 2024 | Aug 19, 2024 | Smith Jacqueline Paula | PETS | Other | Form 4 sale | 601 | $2k | 2.9% | No plan | SEC |
| Jun 2, 2021 | Jun 4, 2021 | Rosenbloom Bruce S | PETS | CFO & Treasurer | Form 4 sale | 6,000 | $255k | 16.4% | Plan not stated | SEC |
| Jan 29, 2021 | Jan 29, 2021 | Formica Frank J | PETS | Director | Form 4 sale | 5,000 | $193k | 8.3% | Plan not stated | SEC |
| Jan 28, 2021 | Jan 29, 2021 | Fulgoni Gian | PETS | Director | Form 4 sale | 12,890 | $607k | 19.4% | Plan not stated | SEC |
| Jan 28, 2021 | Jan 28, 2021 | Rosenbloom Bruce S | PETS | CFO & Treasurer | Form 4 sale | 5,000 | $250k | 12.0% | Plan not stated | SEC |
| Jan 27, 2021 | Jan 28, 2021 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 60,000 | $2.7M | 15.1% | Plan not stated | SEC |
| Jan 13, 2021 | Jan 14, 2021 | Korn Ronald J | PETS | Director | Form 4 sale | 2,000 | $70k | 2.3% | Plan not stated | SEC |
| Dec 24, 2020 | Dec 28, 2020 | Korn Ronald J | PETS | Director | Form 4 sale | 2,000 | $68k | 2.3% | Plan not stated | SEC |
| Dec 18, 2020 | Dec 18, 2020 | Korn Ronald J | PETS | Director | Form 4 sale | 2,000 | $66k | 2.2% | Plan not stated | SEC |
| Nov 12, 2020 | Nov 16, 2020 | Korn Ronald J | PETS | Director | Form 4 sale | 2,000 | $64k | 2.2% | Plan not stated | SEC |
| Aug 28, 2020 | Aug 31, 2020 | Schweitzer Robert C | PETS | Director | Form 4 sale | 7,500 | $272k | 7.3% | Plan not stated | SEC |
| Aug 28, 2020 | Aug 31, 2020 | Formica Frank J | PETS | Director | Form 4 sale | 4,500 | $161k | 7.0% | Plan not stated | SEC |
| Jul 16, 2020 | Jul 20, 2020 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 30,000 | $1.2M | 7.7% | Plan not stated | SEC |
| Apr 29, 2020 | Apr 30, 2020 | Rosenbloom Bruce S | PETS | Chief Financial Officer | Form 4 sale | 3,334 | $133k | 9.6% | Plan not stated | SEC |
| Apr 27, 2020 | Apr 28, 2020 | Rosenbloom Bruce S | PETS | Chief Financial Officer | Form 4 sale | 3,500 | $123k | 9.1% | Plan not stated | SEC |
| Apr 16, 2020 | Apr 17, 2020 | Rosenbloom Bruce S | PETS | Chief Financial Officer | Form 4 sale | 3,500 | $114k | 8.4% | Plan not stated | SEC |
| Apr 7, 2020 | Apr 8, 2020 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 20,000 | $625k | 4.9% | Plan not stated | SEC |
| Apr 6, 2020 | Apr 7, 2020 | Rosenbloom Bruce S | PETS | Chief Financial Officer | Form 4 sale | 3,500 | $105k | 7.7% | Plan not stated | SEC |
| Apr 6, 2020 | Apr 7, 2020 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 30,000 | $900k | 6.8% | Plan not stated | SEC |
| Feb 21, 2020 | Feb 24, 2020 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 10,000 | $290k | 2.2% | Plan not stated | SEC |
| Feb 19, 2020 | Feb 20, 2020 | Rosenbloom Bruce S | PETS | Chief Financial Officer | Form 4 sale | 3,500 | $99k | 7.2% | Plan not stated | SEC |
| Feb 18, 2020 | Feb 19, 2020 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 60,000 | $1.7M | 11.8% | Plan not stated | SEC |
| Oct 23, 2019 | Oct 24, 2019 | Fulgoni Gian | PETS | Director | Form 4 sale | 12,000 | $317k | 16.9% | Plan not stated | SEC |
| Sep 13, 2018 | Sep 14, 2018 | Schweitzer Robert C | PETS | Director | Form 4 sale | 7,500 | $278k | 7.8% | Plan not stated | SEC |
| Jun 12, 2018 | Jun 14, 2018 | Formica Frank J | PETS | Director | Form 4 sale | 5,000 | $209k | 9.3% | Plan not stated | SEC |
| Jan 29, 2018 | Jan 30, 2018 | Korn Ronald J | PETS | Director | Form 4 sale | 5,000 | $242k | 6.8% | Plan not stated | SEC |
| Jan 22, 2018 | Jan 24, 2018 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 10,000 | $570k | 2.1% | Plan not stated | SEC |
| Jan 12, 2018 | Jan 16, 2018 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 40,000 | $2.1M | 7.7% | Unusual | SEC |
| Dec 15, 2017 | Dec 19, 2017 | Fulgoni Gian | PETS | Director | Form 4 sale | 20,000 | $888k | 26.4% | Unusual | SEC |
| Oct 27, 2017 | Oct 31, 2017 | Korn Ronald J | PETS | Director | Form 4 sale | 1,000 | $36k | 1.3% | Plan not stated | SEC |
| Aug 1, 2017 | Aug 2, 2017 | Schweitzer Robert C | PETS | Director | Form 4 sale | 2,500 | $123k | 2.7% | Plan not stated | SEC |
| Jul 28, 2017 | Jul 31, 2017 | Korn Ronald J | PETS | Director | Form 4 sale | 5,000 | $241k | 6.9% | Plan not stated | SEC |
| Jul 27, 2017 | Jul 31, 2017 | Schweitzer Robert C | PETS | Director | Form 4 sale | 5,000 | $243k | 5.6% | Plan not stated | SEC |
| Jul 27, 2017 | Jul 31, 2017 | Rosenbloom Bruce S | PETS | Chief Financial Officer | Form 4 sale | 6,833 | $343k | 26.9% | Unusual | SEC |
| May 16, 2017 | May 16, 2017 | Formica Frank J | PETS | Director | Form 4 sale | 5,000 | $177k | 9.8% | Plan not stated | SEC |
| May 10, 2017 | May 11, 2017 | Korn Ronald J | PETS | Director | Form 4 sale | 3,000 | $96k | 4.0% | Plan not stated | SEC |
| May 8, 2017 | May 9, 2017 | Rosenbloom Bruce S | PETS | CHIEF FINANCIAL OFFICER | Form 4 sale | 9,000 | $243k | 26.3% | Unusual | SEC |
| May 1, 2017 | May 3, 2017 | Rosenbloom Bruce S | PETS | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,500 | $36k | 4.2% | Plan not stated | SEC |
| Dec 13, 2016 | Dec 14, 2016 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 10,000 | $230k | 1.9% | Plan not stated | SEC |
| Dec 9, 2016 | Dec 12, 2016 | Rosenbloom Bruce S | PETS | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,500 | $35k | 4.0% | Plan not stated | SEC |
| Dec 7, 2016 | Dec 7, 2016 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 3,107 | $71k | 0.6% | Plan not stated | SEC |
| Dec 1, 2016 | Dec 5, 2016 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 16,893 | $382k | 3.1% | Plan not stated | SEC |
| Dec 1, 2016 | Dec 5, 2016 | Rosenbloom Bruce S | PETS | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,500 | $34k | 3.9% | Unusual | SEC |
| Nov 25, 2016 | Nov 29, 2016 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 6,274 | $140k | 1.1% | Plan not stated | SEC |
| Nov 21, 2016 | Nov 23, 2016 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 3,726 | $83k | 0.7% | Plan not stated | SEC |
| Nov 16, 2016 | Nov 18, 2016 | Formica Frank J | PETS | Director | Form 4 sale | 10,000 | $218k | 16.4% | Plan not stated | SEC |
| Nov 14, 2016 | Nov 15, 2016 | Rosenbloom Bruce S | PETS | CHIEF FINANCIAL OFFICER | Form 4 sale | 3,000 | $65k | 7.2% | Unusual | SEC |
| Nov 14, 2016 | Nov 15, 2016 | Akdag Menderes | PETS | CEO & President | Form 4 sale | 40,000 | $865k | 6.7% | Unusual | SEC |
| Oct 10, 2016 | Oct 11, 2016 | Rosenbloom Bruce S | PETS | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,500 | $32k | 3.5% | Unusual | SEC |